Arena (ARNA) Ramps as PDUFA Delay May Be Avoided
Tweet
Share
E-mail
Get Alerts ARNA Hot Sheet
Join SI Premium – FREE
With just eight more days until Arena Pharmaceuticals' (NASDAQ: ARNA) FDA PDUFA date (06/27) for potential blockbuster obesity drug Lorcaserin, investors may be feeling more confident that a 3-6 month delay won't come.
Looking at the past announcement from rival Vivus, Inc. (NASDAQ: VVUS) of a three month PDUFA delay for its Qnexa, it should be noted that the delay announcement came eight days ahead of the original scheduled PDUFA date.
This could suggest that if we don't get a delay announcement from Arena today, it won't come at all.
With or without a delay, most expected the FDA will follow the advice of their panel and back Lorcaserin. However, if the company doesn't get the delay it may be able to gain a 'first to market' advantage.
Shares of ARNA last traded at $10.17, up 8.4 percent.
Looking at the past announcement from rival Vivus, Inc. (NASDAQ: VVUS) of a three month PDUFA delay for its Qnexa, it should be noted that the delay announcement came eight days ahead of the original scheduled PDUFA date.
This could suggest that if we don't get a delay announcement from Arena today, it won't come at all.
With or without a delay, most expected the FDA will follow the advice of their panel and back Lorcaserin. However, if the company doesn't get the delay it may be able to gain a 'first to market' advantage.
Shares of ARNA last traded at $10.17, up 8.4 percent.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Affirm stock drops on report Walmart-backed fintech One is launching BNPL; Mizuho says 'concerns overblown'
- Super Micro Computer (SMCI) now down nearly 20%
- Snap (SNAP), Meta (META) gain as House orders sale or ban of TikTok
Create E-mail Alert Related Categories
Momentum Movers, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
